Joel Greenblatt's IMNM Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 10,100 shares of Immunome, Inc. (IMNM) worth $216,948, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in IMNM for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q4 2025, reducing 100 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Immunome (IMNM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunome (IMNM) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -100 | Reduce 0.98% | 10,100 | $21.48 |
| Q1 2025 | +10,200 | New Buy | 10,200 | $6.73 |
Joel Greenblatt's Immunome Investment FAQs
Joel Greenblatt first purchased Immunome, Inc. (IMNM) in Q1 2025, acquiring 10,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Immunome, Inc. (IMNM) for 4 quarters since Q1 2025.
Joel Greenblatt's largest addition to Immunome, Inc. (IMNM) was in Q1 2025, adding 10,200 shares worth $68,646.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 10,100 shares of Immunome, Inc. (IMNM), valued at approximately $216,948.
As of the Q4 2025 filing, Immunome, Inc. (IMNM) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Immunome, Inc. (IMNM) was 10,200 shares, as reported at the end of Q1 2025.